Clinical application of emerging sensor technologies in diabetes management: Consensus guidelines for continuous glucose monitoring (CGM)

被引:86
作者
Hirsch, Irl B. [1 ]
Armstrong, Dana [2 ]
Bergenstal, Richard M. [3 ,4 ]
Buckingham, Bruce [5 ]
Childs, Belinda P. [6 ]
Clarke, William L. [7 ]
Peters, Anne [8 ,9 ]
Wolpert, Howard [10 ]
机构
[1] Univ Washington, Med Ctr Roosevelt, Dept Med, Seattle, WA 98105 USA
[2] Diabet Care Ctr, Salinas, CA USA
[3] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[4] Int Diabet Ctr Pk Nicollet, Minneapolis, MN USA
[5] Stanford Univ, Dept Pediat Endocrinol, Stanford, CA 94305 USA
[6] PA, Mid Amer Diabet Associates, Wichita, KS USA
[7] Univ Virginia Hlth Syst, Div Endocrinol Diabet Pediat, Charlottesville, VA USA
[8] Univ So Calif, Clin Diabet Programs, Los Angeles, CA USA
[9] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
[10] Joslin Diabet Ctr, Insulin Pump Program, Boston, MA 02215 USA
关键词
D O I
10.1089/dia.2008.0016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Continuous glucose monitoring (CGM) is an evolving technology poised to redefine current concepts of glycemic control and optimal diabetes management. To date, there are few randomized studies examining how to most effectively use this new tool. Therefore, a group of eight diabetes specialists heard presentations on continuous glucose sensor technology and then discussed their experience with CGM in order to identify fundamental considerations, objectives, and methods for applying this technology in clinical practice. The group concluded that routine use of CGM, with real-time data showing the rate and direction of glucose change, could revolutionize current approaches to evaluating and managing glycemia. The need for such progress is indicated by the growing prevalence of inadequately treated hyperglycemia. Coordinating financial and educational resources and developing clear protocols for using glucose sensor technology are urgent priorities in promoting wide adoption of CGM by patients and health care providers. Finally, researchers, manufacturers, payers, and advocacy groups must join forces on the policy level to create an environment conducive to managing continuous data, measuring outcomes, and formalizing best practices. © 2008 Mary Ann Liebert, Inc.
引用
收藏
页码:232 / 246
页数:13
相关论文
共 32 条
[1]  
[Anonymous], 2007, DIABETES CARE, DOI DOI 10.2337/DC07-S004
[2]   Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes [J].
Barner, JC ;
Lopez, D .
DIABETES EDUCATOR, 2004, 30 (01) :112-125
[3]   Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes [J].
Bode, BW ;
Schwartz, S ;
Stubbs, HA ;
Block, JE .
DIABETES CARE, 2005, 28 (10) :2361-2366
[4]  
Borch-Johnsen K, 1999, LANCET, V354, P617
[5]   Glycemic variability:: A hemoglobin A1c-independent risk factor for diabetic complications [J].
Brownlee, M ;
Hirsch, IB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (14) :1707-1708
[6]  
Buckingham B., 2005, Curr Opin Endocrinol Diabetes, V12, P273
[7]   Postprandial hyperglycemia and diabetes complications - Is it time to treat? [J].
Ceriello, A .
DIABETES, 2005, 54 (01) :1-7
[8]   Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation - Effects of short- and long-term simvastatin treatment [J].
Ceriello, A ;
Taboga, C ;
Tonutti, L ;
Quagliaro, L ;
Piconi, L ;
Bais, B ;
Da Ros, R ;
Motz, E .
CIRCULATION, 2002, 106 (10) :1211-1218
[9]   The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the diabetes control and complications Trial/Epidemiology of diabetes interventions and complications (DCCT/EDIC) study [J].
Cleary, Patricia A. ;
Orchard, Trevor J. ;
Genuth, Saul ;
Wong, Nathan D. ;
Detrano, Robert ;
Backlund, Jye-Yu C. ;
Zinman, Bernard ;
Jacobson, Alan ;
Sun, Wanjie ;
Lachin, John M. ;
Nathan, David M. .
DIABETES, 2006, 55 (12) :3556-3565
[10]  
*DAIB CONTR COMPL, 2000, NEW ENGL J MED, V342, P381